Delivery Order SPE2DB25D3003-SPE2DB25FPWYA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $56,860.81 to AmerisourceBergen Drug Corp for 60-count bottles of Otezla 30 mg tablets. The contract is non-competitive and utilizes firm fixed pricing, with an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $60,088.59 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) with a completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $11,155.49 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive set-aside contract. The award was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,642.74 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $11,258.73 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packages). This firm fixed price contract, awarded on August 19, 2025, with completion expected by August 20, 2025, carries no set-aside designation and was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,344.96 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packages). This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract valued at $46,287.17. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 3, 2025. AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $12,445.76 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60 count) under a firm fixed-price contract valued at $9,551.10, with an ultimate completion date of June 5, 2025. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999.99 billion through December 2026. The delivery order represents a...
- The Defense Logistics Agency awarded a $19,860.97 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed-price contract represents a non-competitive set-aside and reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. The order is being performed at the contractor's corporate office location in...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPWYADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $44,984.93 to AmerisourceBergen Drug Corp for 60-count bottles of Otezla 30 mg tablets. This contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 12, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio with DLA includes a wide range of pharmaceutical products across multiple therapeutic domains, from specialty medications and vaccines to brand-name and generic drugs. The Troop Support Medical IDC positions AmerisourceBergen to serve customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Otezla delivery order represents a routine transaction within the company's established relationship as a preferred pharmaceutical supplier to the federal government's defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.0k | 8/11/25 |